radio-immunoguided surgery

radio-immunoguided surgery

Surgery A procedure in which radiolabeled substances are administered and tumors are excised based on the location of radioactive signals
References in periodicals archive ?
We are revising our investment rating on the common stock of Neoprobe Corporation from Neutral to Strong Speculative Buy because of our belief that the Company will be announcing an important collaboration for radio-immunoguided surgery (RIGS(R)) sometime within the next two quarters.
We continue to believe Neoprobe's research and development programs with Lymphoseek(TM) and radio-immunoguided surgery (RIGS(R)) are innovative, meet unmet medical needs and will potentially participate in very large markets.
Neoprobe's future market value has the ability to exceed $1 billion with a product in Radio-Immunoguided Surgery (RIGS(R)) that is important enough to be able to change the standard of practice in treating carcinoma of the colon.